Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis
Our data support the added benefit of decreased TB co-burden with expanded ART access. Early diagnosis and immediate linkage to care should be prioritised among PLHIV.
Authors
- Yukteshwar Sookrajh (ORCID: https://orcid.org/0000-0001-9029-5153)
- Nigel Garrett (ORCID: https://orcid.org/0000-0002-4530-234X)
- Lara Lewis (ORCID: https://orcid.org/0000-0001-5373-2086)
- Phelelani Sosibo
- Kogieleum Naidoo (ORCID: https://orcid.org/0000-0002-8874-6661)
- Richard Lessells (ORCID: https://orcid.org/0000-0003-0926-710X)
- Christian Bottomley (ORCID: https://orcid.org/0000-0002-5241-8412)
- Kwabena Asare (ORCID: https://orcid.org/0000-0002-5074-2315)
- Jienchi Dorward (ORCID: https://orcid.org/0000-0001-6072-1430)
- Thokozani Khubone (ORCID: https://orcid.org/0000-0002-2488-6454)
- Johan van der Molen (ORCID: https://orcid.org/0009-0009-7290-7107)
- Ntokozo Siyabonga Mkhize
- Thulani Ngwenya
Institutions
- Centre for the AIDS Programme of Research in South Africa (ZA)
- eThekwini Municipality (ZA)
- University of Oxford (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Addington Hospital (ZA)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- BMJ Global Health
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1136/bmjgh-2024-016631
- Citations
- 3
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Bill and Melinda Gates Foundation
- National Institute for Health and Care Research